Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Green Thumb Industries Inc (OP:GTBIF)

5.510 -0.290 (-5.00%)
Streaming Delayed Price Updated: 1:00 PM EDT, Apr 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Green Thumb Industries Inc

< Previous 1 2 3 4 5 6 7 8 9
...
37 38 Next >
'We've Accepted Mommy-Wine Culture; Why Not Cannabis?'—Meet The Woman Behind The Largest Weed PR Firm In North America
“We’ve accepted mommy-wine culture; why can’t we do the same with cannabis?” says Rosie Mattio, the woman behind North America's largest cannabis PR firm. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stock Movers For March 28, 2025
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stock Gainers And Losers From March 27, 2025
Via Benzinga
Topics Cannabis
Exposures Cannabis
This Week In Cannabis: The CDC's Federal Weed Strategy, Edible Arrangements' New Biz, Global News, Earnings, Musk And More
The cannabis industry sees major regulatory, business and cultural shifts, with new policies, earnings and trends. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Bearish Sentiment Across The Cannabis Space - Check Full Movers For March 13, 2025
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stock Movers For March 10, 2025
Via Benzinga
Topics Cannabis
Exposures Cannabis
This Week In Cannabis: Big Earnings Reports, Ice Cube's New Brand, Trump's Mixed Signals, Germany's Import Boom And Much More
This week in cannabis news: major acquisitions, regulatory battles, earnings rallies and Ice Cube's new brand launch. 
Via Benzinga
Topics Cannabis Government
Exposures Cannabis Political
Cannabis Stocks Cronos, Trulieve, Green Thumb, Verano Trading Up After Earnings: A Full Recap
Why cannabis stocks Cronos, Verano, Trulieve and Green Thumb stocks gained on Thursday. A look at their Q4 earnings, market drivers and future outlook. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stock Valuations Reflect No Expectation Of Federal Reform: Study
Viridian Capital's latest report shows cannabis stocks pricing in no rescheduling or 280E relief, leaving MSOs stuck in valuation limbo. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Top Picks For 2025: Green Thumb Industries
The future of cannabis companies is in the hands of politicians. They hold the keys to all the important potential industry reforms. There’s good news and bad news in this. Green Thumb Industries Inc.... 
Via Talk Markets
Topics Cannabis Stocks / Equities
Exposures Cannabis
The Week In Cannabis: Trump's DEA Pick, Tyson's Reform Push, Dutch Coffee Shop Crisis And More
This week in cannabis: DEA shake-up, contaminated cannabis in the Netherlands, and global market updates. 
Via Benzinga
Topics Cannabis Government
Exposures Cannabis Political
Bearish Sentiment Across The Cannabis Space - Check Full Movers For January 20, 2025
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Legalization Headed For The Ballot Again In Florida: Advocates Launch New Amendment Initiative
Group behind failed attempt to legalize recreational cannabis in FL has launched new initiative for 2026 ballot. Allows adult use with limits and restrictions. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Amplify To Liquidate Cannabis-Focused MJUS ETF As Regulatory Uncertainty Weighs On Sector
Amplify ETFs plans to liquidate MJUS, a cannabis-related ETF, due to regulatory issues. Other cannabis ETFs also struggling with DEA's indecisiveness. 
Via Benzinga
Topics Cannabis ETFs
Exposures Cannabis
DEA Accused Of Bias In Cannabis Rescheduling Hearings: Weed Stocks Plummeted In 2024 As Process Drags On
DEA judge orders agency to respond to allegations of opposing marijuana rescheduling and improper communication with opponents. Cannabis stocks declined in 2024 due to concerns about DEA review. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
EXCLUSIVE: Cannabis Physician Says Surgeon General's Alcohol Cancer Risk Warning Is 'Wake-Up Call'
Surgeon general warns about alcohol's cancer risk, suggests updates to health labels. Cannabis stocks largely rise while alcohol stocks drop. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
The Price Is Right: This Weed Real Estate Stock Proves Conservative Strategies Bring Returns
New Lake Capital Partners (OTC:NLCP), a real estate company focused on cannabis properties, offers an attractive investment with a 9.1% dividend yield, well above the return on 10-year government... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
85% Of Cannabis Companies Report Positive Earnings, But Not All Are Winning - See Who's Leading
85% of the companies analyzed by Beacon Securities achieved positive adjusted EBITDA for the quarter, an increase from 81% in Q2. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Why Cannabis Sales Are Down In Massachusetts And New Mexico: The Numbers Behind The Dip
Massachusetts' average revenue per dispensary dropped to $362k/month, down 8% year-over-year, in New Mexico sales went down 3% in November. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Illinois Cannabis Sales Back On Track In October Hitting $142.3M After Slight September Dip
ollowing a drop in September cannabis sales numbers in Illinois, October figures totaled $142.3 million, a 4.2% increase sequentially, reported New Cannabis Ventures' Alan Brochstein. Cannabis sales... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Is MariMed A Safe Haven In The Wake Of Florida's Cannabis Legalization Defeat?
For investors, MariMed represents a fundamentally strong outlier, but industry-wide challenges remain a drag on stock performance. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Diversify Around And Find Out: Can Vegas Superstore And Florida Sales Boost This Weed Penny Stock?
Is this 40-cent cannabis stock undervalued? Zuanic & Associates dives into its growth potential and market prospects. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Pharma-Grade Cannabis Could Hit Walgreens & CVS—But Can The Industry Survive The FDA?
As the formal review process for rescheduling cannabis unfolds, industry players are closely watching its potential to transform the sector. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Co. Cansortium Refinances Debt With $96.5M Loan Ahead Of Major Merger And Next Phase Of Growth
Cansortium Inc. (CSE: TIUM.U) (OTCQB: CNTMF) announced on Tuesday that it has secured a new senior secured credit agreement of up to $96.5 million with Chicago Atlantic Admin, LLC, as an administrative... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Federal Policy Could Add $3 Billion To Cannabis Industry: On Track To Reach $55 Billion By 2030
According to LeafLink, over the next 2-3 years, 5,000 non-MSO retailers are projected to open in key states, increasing store counts by 70%. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
80% Leverage, 5.5x EBITDA: Is Cresco The High-Risk, High-Reward Play Investors Need?
According to Z&A, its enterprise value (EV) to current sales ratio stands at 1.6x, lower than Curaleaf and Green Thumb, both at 2.2x. 
Via Benzinga
Best And Worst Performing States For Cannabis Sales In 2024: YTD Winners & Losers
BDSA's October 2024 data highlights Maryland as the fastest-growing state for cannabis sales, with a year-to-date increase of 57.8%. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stocks Feel The Burn: Matt Gaetz Bows Out As Trump's Attorney General Nominee
The AdvisorShares Pure US Cannabis ETF (NYSEARCA: MSOS), often viewed as a benchmark for MSOs, dropped by -4.31%, closing at $4.56. 
Via Benzinga
Topics Cannabis ETFs Government
Exposures Cannabis Political
Pre-Rolls, The Avocado Toast Of Cannabis: Why Millennials Are Spending +$100M A Month
Millennials dominate the pre-roll market, accounting for 44.6% of purchases in September 2024, totaling $103.9 million. 
Via Benzinga
Can Trump's Return Save The Cannabis Sector? Debt Mounts As Giants Face Post-Election Reckoning
The post-election landscape raises uncertainty for cannabis MSOs, with investors hoping for potential relief from the new administration. 
Via Benzinga
Topics Cannabis Government
Exposures Cannabis Political
< Previous 1 2 3 4 5 6 7 8 9
...
37 38 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.